Here come the 2019 unicorns: Alector, Gossamer set to launch IPOs donning $1B-plus market caps
Are you ready for swelling biotech IPO valuations?
Alector and Gossamer Bio are set to debut on Nasdaq later this week at market caps of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
